PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: PIPELINE PART 07: MARKET SEGMENTATION BY APPLICATION Market segmentation by application Comparison by application Hematologic pruritus - Market size and forecast 2018-2023 Oncological pruritus - Market size and forecast 2018-2023 Renal pruritus - Market size and forecast 2018-2023 Endocrine pruritus - Market size and forecast 2018-2023 Cholestatic pruritus - Market size and forecast 2018-2023 Market opportunity by application PART 08: MARKET SEGMENTATION BY ROA PART 09: CUSTOMER LANDSCAPE PART 10: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES Market drivers Market challenges PART 13: MARKET TRENDS PART 14: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 15: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Allergan Plc Astellas Pharma Inc. GlaxoSmithKline Plc Pfizer Inc. Sanofi PART 16: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 17: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global pharmaceuticals market Exhibit 03: Segments of global pharmaceuticals market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Global pruritus drugs market pipeline: Overview Exhibit 19: Global pruritus drugs market pipeline: Snapshot Exhibit 20: Application - Market share 2018-2023 (%) Exhibit 21: Comparison by application Exhibit 22: Hematologic pruritus - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Hematologic pruritus - Year-over-year growth 2019-2023 (%) Exhibit 24: Oncological pruritus - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Oncological pruritus - Year-over-year growth 2019-2023 (%) Exhibit 26: Renal pruritus - Market size and forecast 2018-2023 ($ millions) Exhibit 27: Renal pruritus - Year-over-year growth 2019-2023 (%) Exhibit 28: Endocrine pruritus - Market size and forecast 2018-2023 ($ millions) Exhibit 29: Endocrine pruritus - Year-over-year growth 2019-2023 (%) Exhibit 30: Cholestatic pruritus - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Cholestatic pruritus - Year-over-year growth 2019-2023 (%) Exhibit 32: Market opportunity by application Exhibit 33: RoA - Market share Exhibit 34: Few prominent topical drugs Exhibit 35: Customer landscape Exhibit 36: Market share by geography 2018-2023 (%) Exhibit 37: Geographic comparison Exhibit 38: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 39: North America - Year-over-year growth 2019-2023 (%) Exhibit 40: Top 3 countries in North America Exhibit 41: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 42: Europe - Year-over-year growth 2019-2023 (%) Exhibit 43: Top 3 countries in Europe Exhibit 44: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 45: Asia - Year-over-year growth 2019-2023 (%) Exhibit 46: Top 3 countries in Asia Exhibit 47: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 48: ROW - Year-over-year growth 2019-2023 (%) Exhibit 49: Top 3 countries in ROW Exhibit 50: Key leading countries Exhibit 51: Market opportunity Exhibit 52: Indications that are associated with pruritus Exhibit 53: Impact of drivers and challenges Exhibit 54: Vendor landscape Exhibit 55: Landscape disruption Exhibit 56: Vendors covered Exhibit 57: Vendor classification Exhibit 58: Market positioning of vendors Exhibit 59: Allergan Plc - Vendor overview Exhibit 60: Allergan Plc - Business segments Exhibit 61: Allergan Plc - Organizational developments Exhibit 62: Allergan Plc - Geographic focus Exhibit 63: Allergan Plc - Segment focus Exhibit 64: Allergan Plc - Key offerings Exhibit 65: Allergan Plc - Key customers Exhibit 66: Astellas Pharma Inc. - Vendor overview Exhibit 67: Astellas Pharma Inc. - Business segments Exhibit 68: Astellas Pharma Inc. - Organizational developments Exhibit 69: Astellas Pharma Inc. - Geographic focus Exhibit 70: Astellas Pharma Inc. - Key offerings Exhibit 71: Astellas Pharma Inc. - Key customers Exhibit 72: GlaxoSmithKline Plc - Vendor overview Exhibit 73: GlaxoSmithKline Plc - Business segments Exhibit 74: GlaxoSmithKline Plc - Organizational developments Exhibit 75: GlaxoSmithKline Plc - Geographic focus Exhibit 76: GlaxoSmithKline Plc - Segment focus Exhibit 77: GlaxoSmithKline Plc - Key offerings Exhibit 78: GlaxoSmithKline Plc - Key customers Exhibit 79: Pfizer Inc. - Vendor overview Exhibit 80: Pfizer Inc. - Business segments Exhibit 81: Pfizer Inc. - Organizational developments Exhibit 82: Pfizer Inc. - Geographic focus Exhibit 83: Pfizer Inc. - Segment focus Exhibit 84: Pfizer Inc. - Key offerings Exhibit 85: Pfizer Inc. - Key customers Exhibit 86: Sanofi - Vendor overview Exhibit 87: Sanofi - Business segments Exhibit 88: Sanofi - Organizational developments Exhibit 89: Sanofi - Geographic focus Exhibit 90: Sanofi - Segment focus Exhibit 91: Sanofi - Key offerings Exhibit 92: Sanofi - Key customers Exhibit 93: Validation techniques employed for market sizing Exhibit 94: Definition of market positioning of vendors

Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., and Sanofi.